LOCUS       QTZ30664                1233 aa            linear   VRL 20-APR-2021
DEFINITION  surface glycoprotein, partial [Severe acute respiratory syndrome
            coronavirus 2].
ACCESSION   QTZ30664
VERSION     QTZ30664.1
DBSOURCE    accession MW972488.1
KEYWORDS    .
SOURCE      Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  ORGANISM  Severe acute respiratory syndrome coronavirus 2
            Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
            Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
            Betacoronavirus; Sarbecovirus; Betacoronavirus pandemicum.
REFERENCE   1  (residues 1 to 1233)
  AUTHORS   Deng,X., Garcia-Knight,M.A., Khalid,M.M., Servellita,V., Wang,C.,
            Morris,M.K., Sotomayor-Gonzalez,A., Glasner,D.R., Reyes,K.R.,
            Gliwa,A.S., Reddy,N.P., Sanchez San Martin,C., Federman,S.,
            Cheng,J., Balcerek,J., Taylor,J., Streithorst,J.A., Miller,S.,
            Kumar,G.R., Sreekumar,B., Chen,P.Y., Schulze-Gahmen,U., Taha,T.Y.,
            Hayashi,J., Simoneau,C.R., McMahon,S., Lidsky,P.V., Xiao,Y.,
            Hemarajata,P., Green,N.M., Espinosa,A., Kath,C., Haw,M., Bell,J.,
            Hacker,J.K., Hanson,C., Wadford,D.A., Anaya,C., Ferguson,D.,
            Lareau,L.F., Frankino,P.A., Shivram,H., Wyman,S.K., Ott,M.,
            Andino,R. and Chiu,C.Y.
  TITLE     Transmission, infectivity, and antibody neutralization of an
            emerging SARS-CoV-2 variant in California carrying a L452R spike
            protein mutation
  JOURNAL   medRxiv (2021)
   PUBMED   33758899
  REMARK    Publication Status: Online-Only
REFERENCE   2  (residues 1 to 1233)
  AUTHORS   Chiu,C.Y., Deng,X., Wang,C., Servellita,V., Sotomayor-Gonzalez,A.,
            Wyman,S.K., Anaya,C., IDLB COVIDNet,C.D.P.H. and COVID Tracker
            Consortium,C.Z.B.
  TITLE     Direct Submission
  JOURNAL   Submitted (19-APR-2021) Laboratory Medicine, University of
            California, San Francisco, 185 Berry Street, Box 0134, San
            Francisco, CA 94107, USA
COMMENT     Method: conceptual translation.
FEATURES             Location/Qualifiers
     source          1..1233
                     /organism="Severe acute respiratory syndrome coronavirus
                     2"
                     /isolate="SARS-CoV-2/human/USA/CA-IGI-2720/2021"
                     /isolation_source="nasopharyngeal swab"
                     /host="Homo sapiens"
                     /db_xref="taxon:2697049"
                     /geo_loc_name="USA"
                     /collection_date="2021-01-13"
     Protein         <1..1233
                     /product="surface glycoprotein"
     Region          1..>193
                     /region_name="CoV_Spike_S1_NTD"
                     /note="N-terminal domain of the S1 subunit of coronavirus
                     Spike (S) proteins; cl40465"
                     /db_xref="CDD:477362"
     Site            order(1..5,7,127,158..159,184,190,192)
                     /site_type="other"
                     /note="trimer interface [polypeptide binding]"
                     /db_xref="CDD:394949"
     Region          <380..501
                     /region_name="CoV_Spike_S1_RBD"
                     /note="receptor-binding domain of the S1 subunit of
                     coronavirus spike (S) proteins; cl40478"
                     /db_xref="CDD:424109"
     Site            order(398,407..416,449..455,467..468)
                     /site_type="other"
                     /note="receptor binding motif"
                     /db_xref="CDD:394823"
     Region          503..1168
                     /region_name="CoV_Spike_S1-S2_S2"
                     /note="S1/S2 cleavage region and the S2 fusion subunit of
                     coronavirus spike (S) proteins; cl40439"
                     /db_xref="CDD:424070"
     Site            order(632,654..659,669)
                     /site_type="other"
                     /note="S1/S2 cleavage region"
                     /db_xref="CDD:411955"
     Site            758..766
                     /site_type="other"
                     /note="fusion peptide"
                     /db_xref="CDD:411955"
     Site            776..793
                     /site_type="other"
                     /note="internal fusion peptide"
                     /db_xref="CDD:411955"
     Region          878..943
                     /region_name="heptad repeat 1"
                     /note="heptad repeat 1 [structural motif]"
                     /db_xref="CDD:411955"
     Region          1122..1163
                     /region_name="heptad repeat 2"
                     /note="heptad repeat 2 [structural motif]"
                     /db_xref="CDD:411955"
     CDS             1..1233
                     /gene="S"
                     /coded_by="MW972488.1:<21341..25042"
ORIGIN      
        1 kvfrssvlhs tqdlflpffs nvtwfhaihv sgtngtkrfd npvlpfndgv yfasteksni
       61 irgwifgttl dsktqslliv nnatnvvikv cefqfcndpf lgvyyhknnk xxxxxxxxxx
      121 xxxxxxxxxx xxxxxxxdle gkqgnfknlr efvfknidgy fkiyskhtpi nlvrdlpqgf
      181 saleplvdlp igixxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx
      241 xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx
      301 xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx
      361 xxxxxxxxxx xxxxxxxxxd ynyklpddft gcviawnsnn ldskvggnyn ylyrlfrksn
      421 lkpferdist eiyqagstpc ngvegfncyf plqsygfqpt ngvgyqpyrv vvlsfellhs
      481 patvcgpkks tnlvknkcvn fnfngltgtg vltesnkkfl pfqqfgrdia dttdavrdpq
      541 tleilditpc sfggvsvitp gtntsnqvav lyqgvnctev pvaihadqlt ptwrvystgs
      601 nvfqtragcl igaxxxxxxx xxdipigagi casyhtqtns prrarsvasq siiaytmslg
      661 aensvaysnn siaiptnfti svtteilxxx xxxxxxxxxx xxxxxxxxxx nlllqygsfc
      721 tqlnraltgi aveqdkntqe vfaqvkqiyk tppikdfggf nfsqilpdps ksskrsfied
      781 llfnkvtlad agfikqygdc lgdiaardli caqkfngltv lxxxxxxxmi aqytsallag
      841 titsgwtfga gaalqipfam qmayrfngig vtqnvlyenq klianqfnsa igkiqdslsx
      901 xxxxxxxxxx xxnqnaqaln tlvkqlssnf gaissvlndi lsrldkveae vqidrlitgr
      961 lqslqtyvtq qliraaeira sanlaatkms ecvlgqskrv dfcgkgyhlm sfpqsaphgv
     1021 vflhvtyvpa qeknfttapa ichdgkahfp regvfvsngt hwfvtqrnfy epqiittdnt
     1081 fvsgncdvvi givnntvydp lqpeldsfke eldkyfknht spdvdlgdis ginasvvniq
     1141 keidrlneva knlneslidl qelgkyeqyi kwpwyiwlgf iagliaivmv timlccmtsc
     1201 csclkgccsc gscckfdedd sepvlkgvkl hyt
//

